Developer docs
API playgroundTry for free, no card

Search company profiles

biolegis

Full company profile

uuid02m5ap1

Namestring
biolegis
Legal namestring
Biolegis
Websiteurl
biolegis.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Its member firms — including HAVEL & PARTNERS (Czech Republic/Slovakia), Clyde & Co. (United Kingdom), Advokatfirman Delphi (Sweden), Wardyński & Partners (Poland), and 18 other locally leading practices — deliver coordinated cross-border advice in pharmaceutical regulation, healthcare law, biotech intellectual property, medical devices, product liability, competition law, and life sciences M&A. The network operates as a federation: each firm retains its independence and client relationships, while Biolegis provides a single point of contact for multi-jurisdictional mandates and runs a content and webinar program on EU life sciences regulatory developments.

The underlying service offering is professional legal advice delivered by human practitioners; Biolegis does not operate a software product, technology platform, or proprietary AI tooling. Core competencies are concentrated in member-firm expertise, with disclosed engagements spanning long-term daily advisory for a global Swiss medicinal products and medical devices manufacturer, M&A support for Centene (divestment of Ribera Salud Grupo to Vialto Partners) and Fresenius (acquisition of an ambulance center in Brno and INNEF a.s.), and restructuring advice for Immunoflow. Marketing is executed through the Biolegis website (articles and case studies), webinars on specialized regulatory topics, and professional networks.

Biolegis generates revenue indirectly through member firms' professional-services fees, billed under standard law firm models (hourly rates, fixed fees, success fees) on a case-by-case basis. The company itself is private, has no parent, no subsidiaries, no disclosed funding rounds, and no publicly stated revenue. Aggregate network headcount falls in the 1,001-5,000 range per firmographic data, anchored by HAVEL & PARTNERS' 750+ professionals and supplemented by sizable headcount at Clyde & Co., Advokatfirman Delphi (200 staff/150 lawyers), and Wardyński & Partners (150+ lawyers).

Short descriptiontext

Biolegis is a pan-European network of 22 independent law firms across 20 countries providing coordinated, life sciences-specialized legal services to pharmaceutical, biotech, medical device, and healthcare investor clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences legal services, pharmaceutical regulatory law, healthcare law advisory, biotech intellectual property, cross-border legal counsel
Industry3 codes
PRIMARYHLAJACAJ
Public Health Law, Legal Counsel & Regulatory Affairs Offices
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation
NAICS code2 codes
  • Offices of Lawyers541110
  • Offices of Lawyers54111
SIC code1 code
  • Services-Legal Services8111
Product category
Legal Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Legal Services Fees
TypeProfessional Services
Description

Member law firms generate revenue through professional legal services fees charged to life sciences companies and investors across 20 European countries.

biolegis.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Member firms deliver advisory and representation across pharmaceutical regulation, healthcare law, biotech intellectual property, M&A transactions, product liability, competition law, and clinical trials. The network provides clients a single coordination point for cross-border matters while each member firm operates independently in its jurisdiction.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biolegis is a pan-European network of independent law firms providing legal services to life sciences companies and investors across 20 countries. The network does not offer software products or technology platforms; rather, it offers legal expertise through member firms specializing in life sciences, pharmaceutical, and healthcare law. Services include regulatory compliance, mergers and acquisitions, intellectual property, competition law, and product liability advisory across jurisdictions including France, Switzerland, Austria, Ireland, Slovakia, Hungary, Turkey, Spain, Norway, Portugal, Sweden, United Kingdom, Czech Republic, Poland, Italy, Netherlands, Israel, Germany, Denmark, Ukraine, and Belgium.

Product and service5 records
1Pharmaceutical Regulatory Law
CategoryPharmaceutical regulatory law
2Life Sciences M&A and Corporate Transactions
CategoryM&A and corporate law
3Biotech Intellectual Property and Licensing
CategoryIntellectual property law
4Healthcare Law and Corporate Structuring
CategoryHealthcare law
5Commercial, Tax, and Product Liability Advisory
CategoryCommercial and tax law
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierMember FirmTypeOthers
Description

French member firm in the Biolegis network providing life sciences legal expertise

Strategic tierMember FirmTypeOthers
Description

Swiss member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Austrian member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Irish member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Czech and Slovak member firm, largest independent law firm in Central Europe, with specialized life sciences practice

6Szecskay Attorneys at Law
Strategic tierMember FirmTypeOthers
Description

Hungarian member firm in the Biolegis network

biolegis.com
7GUN Partners
Strategic tierMember FirmTypeOthers
Description

Turkish member firm in the Biolegis network

biolegis.com
Strategic tierMember FirmTypeOthers
Description

Spanish member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Norwegian member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Portuguese member firm in the Biolegis network

11Advokatfirman Delphi
Strategic tierMember FirmTypeOthers
Description

Swedish member firm with extensive life sciences practice, offices in Stockholm, Gothenburg, Malmö and Linköping

biolegis.com
Strategic tierMember FirmTypeOthers
Description

UK member firm with offices in London, Dubai, Mumbai and Shanghai, serving life sciences clients globally

Strategic tierMember FirmTypeOthers
Description

Polish member firm since 1988, with offices in Warsaw, Poznań, Wrocław and Kraków

Strategic tierMember FirmTypeOthers
Description

Italian member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Dutch member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Israeli member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

German member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Danish member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Ukrainian member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Belgian member firm in the Biolegis network

Strategic tierMember FirmTypeOthers
Description

Finnish member firm in the Biolegis network

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Meritas is an international legal network of independent law firms across 90+ jurisdictions. Comparable network structure to Biolegis, though generalist; illustrates how federated legal networks compete for cross-border mandates.

TypeBroad incumbent
Description

Latham & Watkins handles premier life sciences M&A, capital markets, and licensing work globally. Competes for the same high-end life sciences matters but as part of a full-service global firm — overlapping capability but broader portfolio than Biolegis's vertical focus.

TypeDirect peer
Description

Bird & Bird is widely regarded as the leading European law firm for life sciences and healthcare with deep regulatory, IP, and commercial practices across the UK and Continental Europe. Directly comparable to Biolegis in vertical specialization, though structured as an integrated firm rather than a federation.

TypeEmerging player
Description

Cooley has built a top-tier life sciences practice focused on biotech, IPOs, and licensing deals across the US and Europe. Strong overlap with Biolegis in biotech client base but US-anchored and integrated rather than European-federated.

TypeBroad incumbent
Description

Sidley Austin has a top-tier Life Sciences practice covering regulatory, IP, and transactional work for global pharma and biotech clients. Comparable in serving the same buyer segment but operates as an integrated global firm rather than a European-federated network.

TypeDirect peer
Description

Arnold & Porter operates a leading Life Sciences & Healthcare Regulatory practice with deep FDA/EMA expertise and a strong European footprint. Directly competes for sophisticated pharma/biotech regulatory mandates and M&A work that Biolegis member firms target.

7McDermott Will & Emery
TypeDirect peer
Description

McDermott Will & Emery has a strongly rated Life Sciences practice with European offices in Germany and the UK. Compares to Biolegis in focusing on regulated pharma/medtech clients and cross-border EU matters.

TypeOthers
Description

Lex Mundi is a global network of independent law firms providing cross-jurisdictional services. Network-level peer: Biolegis operates the same federated model but vertical-focused on life sciences, while Lex Mundi is generalist. Useful proxy for network economics and competitive dynamics.

TypeEmerging player
Description

Reed Smith has an active Life Sciences group spanning the UK and Europe. Comparable mid-sized competitor for European pharma/biotech regulatory and commercial mandates; smaller life sciences bench than Bird & Bird or Hogan Lovells.

TypeBroad incumbent
Description

Hogan Lovells has a globally recognized Life Sciences & Health Care practice spanning regulatory, IP, and transactional work across the US, UK, and Europe. A broad incumbent with overlapping life sciences capability, but as part of a full-service global portfolio rather than a dedicated life sciences network.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

biolegis

Legal Servicesbiolegis.com

Biolegis is a pan-European network of 22 independent law firms across 20 countries providing coordinated, life sciences-specialized legal services to pharmaceutical, biotech, medical device, and healthcare investor clients.

What biolegis does

Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Its member firms — including HAVEL & PARTNERS (Czech Republic/Slovakia), Clyde & Co. (United Kingdom), Advokatfirman Delphi (Sweden), Wardyński & Partners (Poland), and 18 other locally leading practices — deliver coordinated cross-border advice in pharmaceutical regulation, healthcare law, biotech intellectual property, medical devices, product liability, competition law, and life sciences M&A. The network operates as a federation: each firm retains its independence and client relationships, while Biolegis provides a single point of contact for multi-jurisdictional mandates and runs a content and webinar program on EU life sciences regulatory developments.

The underlying service offering is professional legal advice delivered by human practitioners; Biolegis does not operate a software product, technology platform, or proprietary AI tooling. Core competencies are concentrated in member-firm expertise, with disclosed engagements spanning long-term daily advisory for a global Swiss medicinal products and medical devices manufacturer, M&A support for Centene (divestment of Ribera Salud Grupo to Vialto Partners) and Fresenius (acquisition of an ambulance center in Brno and INNEF a.s.), and restructuring advice for Immunoflow. Marketing is executed through the Biolegis website (articles and case studies), webinars on specialized regulatory topics, and professional networks.

Biolegis generates revenue indirectly through member firms' professional-services fees, billed under standard law firm models (hourly rates, fixed fees, success fees) on a case-by-case basis. The company itself is private, has no parent, no subsidiaries, no disclosed funding rounds, and no publicly stated revenue. Aggregate network headcount falls in the 1,001-5,000 range per firmographic data, anchored by HAVEL & PARTNERS' 750+ professionals and supplemented by sizable headcount at Clyde & Co., Advokatfirman Delphi (200 staff/150 lawyers), and Wardyński & Partners (150+ lawyers).

biolegis firmographics

Firmographics
Name
biolegis
Legal name
Biolegis
Website
https://biolegis.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Biolegis is a pan-European network of 22 independent law firms across 20 countries providing coordinated, life sciences-specialized legal services to pharmaceutical, biotech, medical device, and healthcare investor clients.
Ownership category
akta.pro rank

biolegis industry classification

Industry
Product category
Legal Services
NAICS
Offices of Lawyers (541110), Offices of Lawyers (54111)
SIC
Services-Legal Services (8111)
akta.pro industry
PRIMARYHLAJACAJ
Public Health Law, Legal Counsel & Regulatory Affairs Offices
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Policy, Regulation & Compliance Authorities
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPADANAJ
Health, Pharmaceuticals & Medical Devices Regulatory Cooperation
Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation

Keywords

  • Life sciences legal services
  • Pharmaceutical regulatory law
  • Healthcare law advisory
  • Biotech intellectual property
  • Cross-border legal counsel

biolegis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Legal Services Fees: Member law firms generate revenue through professional legal services fees charged to life sciences companies and investors across 20 European countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

biolegis product offering

Product offering

Core offering

Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Member firms deliver advisory and representation across pharmaceutical regulation, healthcare law, biotech intellectual property, M&A transactions, product liability, competition law, and clinical trials. The network provides clients a single coordination point for cross-border matters while each member firm operates independently in its jurisdiction.

Product overview

Biolegis is a pan-European network of independent law firms providing legal services to life sciences companies and investors across 20 countries. The network does not offer software products or technology platforms; rather, it offers legal expertise through member firms specializing in life sciences, pharmaceutical, and healthcare law. Services include regulatory compliance, mergers and acquisitions, intellectual property, competition law, and product liability advisory across jurisdictions including France, Switzerland, Austria, Ireland, Slovakia, Hungary, Turkey, Spain, Norway, Portugal, Sweden, United Kingdom, Czech Republic, Poland, Italy, Netherlands, Israel, Germany, Denmark, Ukraine, and Belgium.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Regulatory Law
  • Life Sciences M&A and Corporate Transactions
  • Biotech Intellectual Property and Licensing
  • Healthcare Law and Corporate Structuring
  • Commercial, Tax, and Product Liability Advisory

Companies that use biolegis

Customer profile

Named customers8 records

Segments2 records

Ideal customer profiles2 records

biolegis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

biolegis partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered member firm.

  • Harlay Avocatsmember firmOthersFrench member firm in the Biolegis network providing life sciences legal expertise
  • Walder Wyss Ltd.member firmOthersSwiss member firm in the Biolegis network
  • Dorda Brugger Jordismember firmOthersAustrian member firm in the Biolegis network
  • Mason Hayes & Curranmember firmOthersIrish member firm in the Biolegis network
  • HAVEL & PARTNERSmember firmOthersCzech and Slovak member firm, largest independent law firm in Central Europe, with specialized life sciences practice
  • Szecskay Attorneys at Lawmember firmOthersHungarian member firm in the Biolegis network
  • GUN Partnersmember firmOthersTurkish member firm in the Biolegis network
  • Lenermember firmOthersSpanish member firm in the Biolegis network
  • Simonsen Vogt Wiigmember firmOthersNorwegian member firm in the Biolegis network
  • Coelho Ribeiro & Associadosmember firmOthersPortuguese member firm in the Biolegis network
  • Advokatfirman Delphimember firmOthersSwedish member firm with extensive life sciences practice, offices in Stockholm, Gothenburg, Malmö and Linköping
  • Clyde & Co. LLPmember firmOthersUK member firm with offices in London, Dubai, Mumbai and Shanghai, serving life sciences clients globally
  • Wardyński & Partnersmember firmOthersPolish member firm since 1988, with offices in Warsaw, Poznań, Wrocław and Kraków
  • Portolano Cavallomember firmOthersItalian member firm in the Biolegis network
  • Kennedy Van der Laanmember firmOthersDutch member firm in the Biolegis network
  • Gornitzky & Co.member firmOthersIsraeli member firm in the Biolegis network
  • SKW Schwarzmember firmOthersGerman member firm in the Biolegis network
  • Gorrissen Federspielmember firmOthersDanish member firm in the Biolegis network
  • Astersmember firmOthersUkrainian member firm in the Biolegis network
  • Altiusmember firmOthersBelgian member firm in the Biolegis network
  • Attorneys at Law Borenius Ltd.member firmOthersFinnish member firm in the Biolegis network

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

biolegis competitors and assessment

Company assessment

Others

  • Meritas: Meritas is an international legal network of independent law firms across 90+ jurisdictions. Comparable network structure to Biolegis, though generalist; illustrates how federated legal networks compete for cross-border mandates.
  • Lex Mundi: Lex Mundi is a global network of independent law firms providing cross-jurisdictional services. Network-level peer: Biolegis operates the same federated model but vertical-focused on life sciences, while Lex Mundi is generalist. Useful proxy for network economics and competitive dynamics.

Broad incumbents

  • Latham & Watkins: Latham & Watkins handles premier life sciences M&A, capital markets, and licensing work globally. Competes for the same high-end life sciences matters but as part of a full-service global firm — overlapping capability but broader portfolio than Biolegis's vertical focus.
  • Sidley Austin: Sidley Austin has a top-tier Life Sciences practice covering regulatory, IP, and transactional work for global pharma and biotech clients. Comparable in serving the same buyer segment but operates as an integrated global firm rather than a European-federated network.
  • Hogan Lovells: Hogan Lovells has a globally recognized Life Sciences & Health Care practice spanning regulatory, IP, and transactional work across the US, UK, and Europe. A broad incumbent with overlapping life sciences capability, but as part of a full-service global portfolio rather than a dedicated life sciences network.

Direct peers

  • Bird & Bird: Bird & Bird is widely regarded as the leading European law firm for life sciences and healthcare with deep regulatory, IP, and commercial practices across the UK and Continental Europe. Directly comparable to Biolegis in vertical specialization, though structured as an integrated firm rather than a federation.
  • Arnold & Porter: Arnold & Porter operates a leading Life Sciences & Healthcare Regulatory practice with deep FDA/EMA expertise and a strong European footprint. Directly competes for sophisticated pharma/biotech regulatory mandates and M&A work that Biolegis member firms target.
  • McDermott Will & Emery: McDermott Will & Emery has a strongly rated Life Sciences practice with European offices in Germany and the UK. Compares to Biolegis in focusing on regulated pharma/medtech clients and cross-border EU matters.

Emerging players

  • Cooley LLP: Cooley has built a top-tier life sciences practice focused on biotech, IPOs, and licensing deals across the US and Europe. Strong overlap with Biolegis in biotech client base but US-anchored and integrated rather than European-federated.
  • Reed Smith: Reed Smith has an active Life Sciences group spanning the UK and Europe. Comparable mid-sized competitor for European pharma/biotech regulatory and commercial mandates; smaller life sciences bench than Bird & Bird or Hogan Lovells.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

biolegis social profiles

Digital presence

biolegis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

biolegis leadership team

Management profile

Number of profiles

biolegis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

biolegis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biolegis

What does biolegis do?

Biolegis is a pan-European network of independent law firms providing specialized legal services to life sciences companies and investors across 20 countries. Member firms deliver advisory and representation across pharmaceutical regulation, healthcare law, biotech intellectual property, M&A transactions, product liability, competition law, and clinical trials. The network provides clients a single coordination point for cross-border matters while each member firm operates independently in its jurisdiction.

Is biolegis a public or private company?

biolegis is a private company. It is classified as unknown and is currently operating.

When was biolegis founded?

biolegis was founded in -1. It employs 1 to 10 people.

How does biolegis make money?

One revenue line is on record: legal Services Fees.

Who are biolegis's main competitors?

Others on record are Meritas and Lex Mundi. Broad incumbents are Latham & Watkins, Sidley Austin and Hogan Lovells. Direct peers are Bird & Bird, Arnold & Porter and McDermott Will & Emery. Emerging players are Cooley LLP and Reed Smith.

Does biolegis have an API?

No public API is recorded for biolegis.

What industry is biolegis in?

biolegis's product category is Legal Services. Its primary akta.pro industry code is HLAJACAJ, Public Health Law, Legal Counsel & Regulatory Affairs Offices, with a secondary code of HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 541110 and its SIC code is 8111.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales